User menu

Toll-like receptor 4 modulation as a strategy to treat sepsis.

Bibliographic reference Wittebole, Xavier ; Castanares Zapatero, Diego ; Laterre, Pierre-François. Toll-like receptor 4 modulation as a strategy to treat sepsis.. In: Mediators of Inflammation, Vol. 2010, p. 568396 (2010)
Permanent URL http://hdl.handle.net/2078.1/32125
  1. Friedman Gilberto, Silva Eliezer, Vincent Jean-Louis, Has the mortality of septic shock changed with time? : , 10.1097/00003246-199812000-00045
  2. Martin Greg S., Mannino David M., Eaton Stephanie, Moss Marc, The Epidemiology of Sepsis in the United States from 1979 through 2000, 10.1056/nejmoa022139
  3. Vincent Jean-Louis, Sakr Yasser, Sprung Charles L., Ranieri V Marco, Reinhart Konrad, Gerlach Herwig, Moreno Rui, Carlet Jean, Le Gall Jean-Roger, Payen Didier, Sepsis in European intensive care units: Results of the SOAP study* : , 10.1097/01.ccm.0000194725.48928.3a
  4. Medzhitov Ruslan, Preston-Hurlburt Paula, Janeway Charles A., A human homologue of the Drosophila Toll protein signals activation of adaptive immunity, 10.1038/41131
  5. Poltorak A., Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene, 10.1126/science.282.5396.2085
  6. Journal of Immunology, 162, 3749 (1999)
  7. Lemaitre Bruno, Nicolas Emmanuelle, Michaut Lydia, Reichhart Jean-Marc, Hoffmann Jules A, The Dorsoventral Regulatory Gene Cassette spätzle/Toll/cactus Controls the Potent Antifungal Response in Drosophila Adults, 10.1016/s0092-8674(00)80172-5
  8. Medzhitov Ruslan, Toll-like receptors and innate immunity, 10.1038/35100529
  9. Takeda K., Toll-like receptors in innate immunity, 10.1093/intimm/dxh186
  10. Akira Shizuo, Uematsu Satoshi, Takeuchi Osamu, Pathogen Recognition and Innate Immunity, 10.1016/j.cell.2006.02.015
  11. Tsujimoto Hironori, Ono Satoshi, Efron Philip A., Scumpia Philip O., Moldawer Lyle L., Mochizuki Hidetaka, ROLE OF TOLL-LIKE RECEPTORS IN THE DEVELOPMENT OF SEPSIS : , 10.1097/shk.0b013e318157ee55
  12. Salomão Reinaldo, Martins Paulo Sérgio, Brunialti Milena Karina Colo, Fernandes Maria da Luz, Martos Leandro S.W., Mendes Marialice Erdelyi, Gomes Natália E., Rigato Otelo, TLR SIGNALING PATHWAY IN PATIENTS WITH SEPSIS : , 10.1097/shk.0b013e318181af2a
  13. Weighardt Heike, Holzmann Bernhard, Role of Toll-like receptor responses for sepsis pathogenesis, 10.1016/j.imbio.2007.09.010
  14. Miyake K., Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells, 10.1084/jem.180.4.1217
  15. Journal of Immunology, 161, 1348 (1998)
  16. Divanovic Senad, Trompette Aurelien, Atabani Sowsan F., Madan Rajat, Golenbock Douglas T., Visintin Alberto, Finberg Robert W., Tarakhovsky Alexander, Vogel Stefanie N., Belkaid Yasmine, Kurt-Jones Evelyn A., Karp Christopher L., Inhibition of TLR-4/MD-2 signaling by RP105/MD-1, 10.1179/096805105x67300
  17. Divanovic Senad, Trompette Aurelien, Atabani Sowsan F, Madan Rajat, Golenbock Douglas T, Visintin Alberto, Finberg Robert W, Tarakhovsky Alexander, Vogel Stefanie N, Belkaid Yasmine, Kurt-Jones Evelyn A, Karp Christopher L, Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105, 10.1038/ni1198
  18. Wittebole X., Coyle S. M., Kumar A., Goshima M., Lowry S. F., Calvano S. E., Expression of tumour necrosis factor receptor and Toll-like receptor 2 and 4 on peripheral blood leucocytes of human volunteers after endotoxin challenge: a comparison of flow cytometric light scatter and immunofluorescence gating, 10.1111/j.1365-2249.2005.02831.x
  19. H??rter Luc, Mica Ladislav, Stocker Reto, Trentz Otmar, Keel Marius, INCREASED EXPRESSION OF TOLL-LIKE RECEPTOR-2 AND -4 ON LEUKOCYTES FROM PATIENTS WITH SEPSIS : , 10.1097/01.shk.0000142256.23382.5d
  20. European Journal of Medical Research, 10, 319 (2005)
  21. Journal of the American College of Surgeons, 178, 132 (1994)
  22. Iwami K.-i., Matsuguchi T., Masuda A., Kikuchi T., Musikacharoen T., Yoshikai Y., Cutting Edge: Naturally Occurring Soluble Form of Mouse Toll-Like Receptor 4 Inhibits Lipopolysaccharide Signaling, 10.4049/jimmunol.165.12.6682
  23. Roger T., Froidevaux C., Le Roy D., Reymond M. K., Chanson A.-L., Mauri D., Burns K., Riederer B. M., Akira S., Calandra T., Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4, 10.1073/pnas.0808146106
  24. Gross P., Brandl K., Dierkes C., Scholmerich J., Salzberger B., Gluck T., Falk W., Lipopolysaccharide-Trap-Fc, a Multifunctional Agent To Battle Gram-Negative Bacteria, 10.1128/iai.00004-09
  25. Christ W., Asano O, Robidoux A., Perez M, Wang Y, Dubuc G., Gavin W., Hawkins L., McGuinness P., Mullarkey M., et al., E5531, a pure endotoxin antagonist of high potency, 10.1126/science.7701344
  26. Bunnell Eugene, Lynn Melvyn, Habet Kalim, Neumann Alex, Perdomo Carlos A., Friedhoff Lawrence T., Rogers Sharon L., Parrillo Joseph E., A lipid A analog, E5531, blocks the endotoxin response in human volunteers with experimental endotoxemia : , 10.1097/00003246-200008000-00005
  27. Antimicrobial Agents and Chemotherapy, 43, 2562 (1999)
  28. Rose J. R., Mullarkey M. A., Christ W. J., Hawkins L. D., Lynn M., Kishi Y., Wasan K. M., Peteherych K., Rossignol D. P., Consequences of Interaction of a Lipophilic Endotoxin Antagonist with Plasma Lipoproteins, 10.1128/aac.44.3.504-510.2000
  29. Hawkins Lynn, Christ William, Rossignol Daniel, Inhibition of Endotoxin Response by Synthetic TLR4 Antagonists, 10.2174/1568026043388123
  30. Mullarkey M., Inhibition of Endotoxin Response by E5564, a Novel Toll-Like Receptor 4-Directed Endotoxin Antagonist, 10.1124/jpet.102.044487
  31. Kim Ho Min, Park Beom Seok, Kim Jung-In, Kim Sung Eun, Lee Judong, Oh Se Cheol, Enkhbayar Purevjav, Matsushima Norio, Lee Hayyoung, Yoo Ook Joon, Lee Jie-Oh, Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran, 10.1016/j.cell.2007.08.002
  32. Mullarkey M., Inhibition of Endotoxin Response by E5564, a Novel Toll-Like Receptor 4-Directed Endotoxin Antagonist, 10.1124/jpet.102.044487
  33. Czeslick E., Struppert A., Simm A., Sablotzki A., E5564 (Eritoran) inhibits lipopolysaccharide-induced cytokine production in human blood monocytes, 10.1007/s00011-006-6057-3
  34. Rossignol Daniel P., Wong Nancy, Noveck Robert, Lynn Melvyn, Continuous pharmacodynamic activity of eritoran tetrasodium, a TLR4 antagonist, during intermittent intravenous infusion into normal volunteers, 10.1177/1753425908099173
  35. Lynn Melvyn, Rossignol Daniel P., Wheeler Janice L., Kao Richard J., Perdomo Carlos A., Noveck Robert, Vargas Ramon, D’Angelo Tony, Gotzkowsky Sandra, McMahon F. Gilbert, Blocking of Responses to Endotoxin by E5564 in Healthy Volunteers with Experimental Endotoxemia, 10.1086/367990
  36. Tidswell Mark, Tillis William, LaRosa Steven P., Lynn Melvyn, Wittek Alec E., Kao Richard, Wheeler Janice, Gogate Jagadish, Opal Steven M., Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis* : , 10.1097/ccm.0b013e3181b07b78
  37. Frantz Stefan, Kobzik Lester, Kim Young-Dae, Fukazawa Ryuji, Medzhitov Ruslan, Lee Richard T., Kelly Ralph A., Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium, 10.1172/jci6709
  38. Baumgarten Georg, Knuefermann Pascal, Schuhmacher Gerrit, Verv??lgyi Volker, von Rappard Joscha, Dreiner Ulrike, Fink Klaus, Djoufack Chryso, Hoeft Andreas, Groh?? Christian, Knowlton A A, Meyer Rainer, TOLL-LIKE RECEPTOR 4, NITRIC OXIDE, AND MYOCARDIAL DEPRESSION IN ENDOTOXEMIA : , 10.1097/01.shk.0000196498.57306.a6
  39. Ehrentraut S., Frede S., Stapel H., Mengden T., Grohe C., Fandrey J., Meyer R., Baumgarten G., Antagonism of Lipopolysaccharide-Induced Blood Pressure Attenuation and Vascular Contractility, 10.1161/atvbaha.107.146100
  40. Shimamoto A., Inhibition of Toll-like Receptor 4 With Eritoran Attenuates Myocardial Ischemia-Reperfusion Injury, 10.1161/circulationaha.105.000901
  41. Bennett-Guerrero Elliott, Grocott Hilary P., Levy Jerrold H., Stierer Kevin A., Hogue Charles W., Cheung Albert T., Newman Mark F., Carter Alison A., Rossignol Daniel P., Collard Charles D., A Phase II, Double-Blind, Placebo-Controlled, Ascending-Dose Study of Eritoran (E5564), a Lipid A Antagonist, in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass : , 10.1213/01.ane.0000253501.07183.2a
  42. Yamada Masami, Ichikawa Takashi, Ii Masayuki, Sunamoto Mie, Itoh Katsumi, Tamura Norikazu, Kitazaki Tomoyuki, Discovery of Novel and Potent Small-Molecule Inhibitors of NO and Cytokine Production as Antisepsis Agents:  Synthesis and Biological Activity of Alkyl 6-(N-Substituted sulfamoyl)cyclohex-1-ene-1-carboxylate, 10.1021/jm050623t
  43. Ii M., A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling, 10.1124/mol.105.019695
  44. Kawamoto Tomohiro, Ii Masayuki, Kitazaki Tomoyuki, Iizawa Yuji, Kimura Hiroyuki, TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain, 10.1016/j.ejphar.2008.01.026
  45. Takashima K, Matsunaga N, Yoshimatsu M, Hazeki K, Kaisho T, Uekata M, Hazeki O, Akira S, Iizawa Y, Ii M, Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model, 10.1111/j.1476-5381.2009.00297.x
  46. Sha Takukyu, Sunamoto Mie, Kitazaki Tomoyuki, Sato Jun, Ii Masayuki, Iizawa Yuji, Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model, 10.1016/j.ejphar.2007.06.027
  47. Kuno Masamune, Nemoto Kayo, Ninomiya Norifumi, Inagaki Eiji, Kubota Minoru, Matsumoto Tatsumi, Yokota Hiroyuki, THE NOVEL SELECTIVE TOLL-LIKE RECEPTOR 4 SIGNAL TRANSDUCTION INHIBITOR TAK-242 PREVENTS ENDOTOXAEMIA IN CONSCIOUS GUINEA-PIGS, 10.1111/j.1440-1681.2008.05121.x
  48. Journal of Immunology, 161, 5534 (1998)
  49. Thieblemont Nathalie, Wright Samuel D., Transport of Bacterial Lipopolysaccharide to the Golgi Apparatus, 10.1084/jem.190.4.523
  50. Cellular & Molecular Immunology, 1, 373 (2004)
  51. Park Boyoun, Brinkmann Melanie M, Spooner Eric, Lee Clarissa C, Kim You-Me, Ploegh Hidde L, Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9, 10.1038/ni.1669
  52. Sepulveda Fernando E., Maschalidi Sophia, Colisson Renaud, Heslop Lea, Ghirelli Cristina, Sakka Emna, Lennon-Duménil Ana-Maria, Amigorena Sebastian, Cabanie Lucien, Manoury Bénédicte, Critical Role for Asparagine Endopeptidase in Endocytic Toll-like Receptor Signaling in Dendritic Cells, 10.1016/j.immuni.2009.09.013
  53. American Journal of Physiology, 274, R1058 (1998)
  54. Hong Zhou, Jiang Zheng, Liangxi Wang, Guofu Ding, Ping Luo, Yongling Lu, Wendong Pan, Minghai Wang, Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release, 10.1016/j.intimp.2003.12.006
  55. Yasuda H., Leelahavanichkul A., Tsunoda S., Dear J. W., Takahashi Y., Ito S., Hu X., Zhou H., Doi K., Childs R., Klinman D. M., Yuen P. S. T., Star R. A., Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury, 10.1152/ajprenal.00461.2007
  56. Croatian Medical Journal, 47, 825 (2006)
  57. Yu M., Shao D., Feng X., Duan M., Xu J., Effects of ketamine on pulmonary TLR4 expression and NF-kappa B activation during endotoxemia in rats, 10.1358/mf.2007.29.6.1119165
  58. Yu Min, Shao Danbing, Liu Jian, Zhu Juan, Zhang Zhijie, Xu Jianguo, Effects of ketamine on levels of cytokines, NF-κB and TLRs in rat intestine during CLP-induced sepsis, 10.1016/j.intimp.2007.04.003
  59. Yu Min, Shao Danbing, Yang Rong, Feng Xiaomei, Zhu Sihai, Xu Jianguo, Effects of Ketamine on Pulmonary Inflammatory Responses and Survival in Rats Exposed to Polymicrobial Sepsis, 10.18433/j3rp46
  60. Chen Ta-Liang, Chang Chia-Chen, Lin Yi-Ling, Ueng Yune-Fang, Chen Ruei-Ming, Signal-transducing mechanisms of ketamine-caused inhibition of interleukin-1β gene expression in lipopolysaccharide-stimulated murine macrophage-like Raw 264.7 cells, 10.1016/j.taap.2009.06.013
  61. Tracey Kevin J., Borovikova Lyudmila V., Ivanova Svetlana, Zhang Minghuang, Yang Huan, Botchkina Galina I., Watkins Linda R., Wang Haichao, Abumrad Naji, Eaton John W., 10.1038/35013070
  62. Wittebole X., Hahm S., Coyle S. M., Kumar A., Calvano S. E., Lowry S. F., Nicotine exposure alters in vivo human responses to endotoxin, 10.1111/j.1365-2249.2006.03248.x
  63. Wang Hong, Yu Man, Ochani Mahendar, Amella Carol Ann, Tanovic Mahira, Susarla Seenu, Li Jian Hua, Wang Haichao, Yang Huan, Ulloa Luis, Al-Abed Yousef, Czura Christopher J., Tracey Kevin J., Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation, 10.1038/nature01339
  64. de Jonge Wouter J, van der Zanden Esmerij P, The Frans O, Bijlsma Maarten F, van Westerloo David J, Bennink Roelof J, Berthoud Hans-Rudolf, Uematsu Satoshi, Akira Shizuo, van den Wijngaard Rene M, Boeckxstaens Guy E, Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway, 10.1038/ni1229
  65. Yoshikawa H., Kurokawa M., Ozaki N., Nara K., Atou K., Takada E., Kamochi H., Suzuki N., Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-?B phosphorylation and nuclear factor-?B transcriptional activity through nicotinic acetylcholine receptor ?7, 10.1111/j.1365-2249.2006.03169.x
  66. Kox Matthijs, van Velzen Jeroen F., Pompe Jan C., Hoedemaekers Cornelia W., van der Hoeven Johannes G., Pickkers Peter, GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation, 10.1016/j.bcp.2009.06.096
  67. Hamano Ryosuke, Takahashi Hideo Kohka, Iwagaki Hiromi, Yoshino Tadashi, Nishibori Masahiro, Tanaka Noriaki, STIMULATION OF ??7 NICOTINIC ACETYLCHOLINE RECEPTOR INHIBITS CD14 AND THE TOLL-LIKE RECEPTOR 4 EXPRESSION IN HUMAN MONOCYTES : , 10.1097/01.shk.0000228168.86845.60
  68. Bsibsi Malika, Ravid Rivka, Gveric Djordje, van Noort Johannes M., Broad Expression of Toll-Like Receptors in the Human Central Nervous System, 10.1093/jnen/61.11.1013
  69. Sacerdote Paola, Opioid-induced immunosuppression : , 10.1097/spc.0b013e3282f5272e
  70. Guo L. -H., Schluesener H. J., The innate immunity of the central nervous system in chronic pain: The role of Toll-like receptors, 10.1007/s00018-007-6494-3
  71. Hutchinson Mark R., Zhang Yingning, Shridhar Mitesh, Evans John H., Buchanan Madison M., Zhao Tina X., Slivka Peter F., Coats Benjamen D., Rezvani Niloofar, Wieseler Julie, Hughes Travis S., Landgraf Kyle E., Chan Stefanie, Fong Stephanie, Phipps Simon, Falke Joseph J., Leinwand Leslie A., Maier Steven F., Yin Hang, Rice Kenner C., Watkins Linda R., Evidence that opioids may have toll-like receptor 4 and MD-2 effects, 10.1016/j.bbi.2009.08.004
  72. Methe H., Statins Decrease Toll-Like Receptor 4 Expression and Downstream Signaling in Human CD14+ Monocytes, 10.1161/01.atv.0000168410.44722.86
  73. Niessner Alexander, Steiner Sabine, Speidl Walter S., Pleiner Johannes, Seidinger Daniela, Maurer Gerald, Goronzy Jörg J., Weyand Cornelia M., Kopp Christoph W., Huber Kurt, Wolzt Michael, Wojta Johann, Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo, 10.1016/j.atherosclerosis.2005.12.022
  74. Földes Gábor, von Haehling Stephan, Okonko Darlington O., Jankowska Ewa A., Poole-Wilson Philip A., Anker Stefan D., Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure, 10.1016/j.ijcard.2006.12.024
  75. Boekholdt S. M., Variants of Toll-Like Receptor 4 Modify the Efficacy of Statin Therapy and the Risk of Cardiovascular Events, 10.1161/01.cir.0000068311.40161.28
  76. Hodgkinson Conrad P., Ye Shu, Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression : , 10.1097/fpc.0b013e3283050aff
  77. Kirsch Christopher, Eckert Gunter P, Mueller Walter E, Statin effects on cholesterol micro-domains in brain plasma membranes, 10.1016/s0006-2952(02)01654-4
  78. Tleyjeh Imad M., Statins for the Prevention and Treatment of Infections : A Systematic Review and Meta-analysis, 10.1001/archinternmed.2009.286
  79. American Journal of Physiology, 277, F157 (1999)
  80. Horiuchi H., Nagata I., Komoriya K., Protective effect of vitamin D3 analogues on endotoxin shock in mice, 10.1007/bf01986584
  81. International Journal of Medical Sciences, 4, 190 (2007)
  82. Liu P. T., Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response, 10.1126/science.1123933
  83. Sorensen O. E., Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3, 10.1182/blood.v97.12.3951
  84. Zanetti M., Cathelicidins, multifunctional peptides of the innate immunity, 10.1189/jlb.0403147
  85. Sadeghi Kambis, Wessner Barbara, Laggner Ute, Ploder Martin, Tamandl Dietmar, Friedl Josef, Zügel Ullrich, Steinmeyer Andreas, Pollak Arnold, Roth Erich, Boltz-Nitulescu George, Spittler Andreas, Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns, 10.1002/eji.200425995
  86. Equils O., Naiki Y., Shapiro A. M., Michelsen K., Lu D., Adams J., Jordan S., 1,25-Dihydroxyvitamin D3 inhibits lipopolysaccharide-induced immune activation in human endothelial cells, 10.1111/j.1365-2249.2005.02961.x
  87. Jeng Leo, Yamshchikov Alexandra V, Judd Suzanne E, Blumberg Henry M, Martin Gregory S, Ziegler Thomas R, Tangpricha Vin, Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis, 10.1186/1479-5876-7-28
  88. Handa O., Yoshida N., Fujita N., Tanaka Y., Ueda M., Takagi T., Kokura S., Naito Y., Okanoue T., Yoshikawa T., Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors, 10.1007/s00011-006-6056-4
  89. Ohara Tadashi, Kanoh Yuhsaku, Yoshino Keiichi, Kitajima Masaki, Effects of Lansoprazole on the Lipopolysaccharide-Stimulated Toll-Like Receptor 4 Signal Transduction Systems: A Study Using the 293hTLR4/MD2-CD14 Cells, 10.3164/jcbn.09-42
  90. Huang Ya-Hsien, Tsai Pei-Shan, Kai Yun-Fang, Yang Chen-Hsien, Huang Chun-Jen, Lidocaine Inhibition of Inducible Nitric Oxide Synthase and Cationic Amino Acid Transporter-2 Transcription in Activated Murine Macrophages May Involve Voltage-Sensitive Na+ Channel : , 10.1213/01.ane.0000219593.15109.db
  91. Lee Ping-Ying, Tsai Pei-Shan, Huang Ya-Hsien, Huang Chun-Jen, INHIBITION OF TOLL-LIKE RECEPTOR-4, NUCLEAR FACTOR-κB AND MITOGEN-ACTIVATED PROTEIN KINASE BY LIGNOCAINE MAY INVOLVE VOLTAGE-SENSITIVE SODIUM CHANNELS, 10.1111/j.1440-1681.2008.04962.x
  92. Feng Guang, Liu Su, Wang Guang-Lei, Liu Gong-Jian, Lidocaine Attenuates Lipopolysaccharide-Induced Acute Lung Injury through Inhibiting NF-κB Activation, 10.1159/000107792
  93. Wang Hua-Dong, Lu Da-Xiang, Qi Ren-Bin, Therapeutic strategies targeting the LPS signaling and cytokines, 10.1016/j.pathophys.2009.02.006